Home | Welcome to Contract Pharma   
Last Updated Thursday, April 17 2014
Print RSS Feed

Breaking News

Related Searches:
November 22, 2010
Boehringer Ingelheim and F-star, an antibody engineering company based in Vienna, Austria, have entered a collaboration and license agreement for the discovery of new antibody-derived therapeutic products using F-star’s Modular Antibody Technology.  Read More »
November 19, 2010
Bayer plans to restructure in order invest its resources in growing the company and enhancing its capabilities.   Read More »
November 19, 2010
Baxter has entered into a definitive agreement to acquire all of the hemophilia-related assets of Archemix, a privately-held biopharmaceutical company.  Read More »
November 19, 2010
Amgen received approval from the FDA for XGEVA (denosumab), the first RANK Ligand inhibitor for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors.  Read More »
November 19, 2010
Pfizer’s Phase III trial studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC) met its primary endpoint, demonstrating significantly extended progression-free survival (PFS) when co  Read More »
November 17, 2010
Setbacks after Genentech acquisition lead to $2.4 billion cost-cutting  Read More »
November 17, 2010
U.S., EU deal to speed hybrid detailing model  Read More »
November 17, 2010
DOS platforms to support Eisai portfolio  Read More »
November 16, 2010
Halaven injection adds new option in metastatic breast cancer  Read More »
November 16, 2010
Avecia to expand QMS as oligonucleotides advance  Read More »
November 16, 2010
Aardema to serve as Tox-CSO  Read More »
November 15, 2010
Central lab will review CyPath slides  Read More »
November 15, 2010
SURE platform to Support of Zyngenia’s Zybody program  Read More »
November 15, 2010
arYla to open new ways to optimize therapeutic and diagnostic antibodies  Read More »
November 12, 2010
Laureate Pharma has established a Regulatory Affairs group and has appointed Robert G. Burford, Ph.D.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On